Knowledge

What Is the Use of Tilmicosin in Swine Respiratory Disease

Nov 06, 2024 Leave a message

Tilmicosin is a semi-synthetic macrolide antibiotic derived from tylosin and used exclusively in veterinary medicine. In swine production, it is primarily applied to the management of respiratory infections caused by a group of well-known bacterial pathogens. Tilmicosin carries the CAS number 108050-54-0.

What Is Tilmicosin?

Tilmicosin belongs to the macrolide class of antibiotics, which are characterised by a large macrocyclic lactone ring in their molecular structure. It is synthesised from tylosin and has been developed to provide improved stability and a longer duration of activity in animals. It is available in feed, water-soluble and injectable formulations depending on the species and the approved product.

How Tilmicosin Works Against Bacteria

Tilmicosin inhibits bacterial protein synthesis by binding reversibly to the 50S ribosomal subunit of susceptible bacteria. This blocks the elongation of peptide chains and prevents the bacteria from producing essential proteins. The result is a bacteriostatic to bactericidal effect, depending on the concentration and the susceptibility of the target organism. Its activity is particularly strong against Mycoplasma, Pasteurella and Haemophilus species, and against many Gram-positive organisms such as Corynebacterium and Streptococcus species.

Main Target Pathogens in Swine

In swine, tilmicosin is used against the pathogens most frequently associated with respiratory disease complexes. The primary targets include Actinobacillus pleuropneumoniae, the cause of porcine pleuropneumonia, and Pasteurella multocida, a major contributor to enzootic pneumonia. Mycoplasma species, which often initiate or aggravate respiratory disease in growing pigs, are also highly susceptible to tilmicosin.

Use in Swine Respiratory Disease Management

Respiratory infections are among the most economically important diseases in pig production. Tilmicosin is used as part of a herd health programme to treat outbreaks and, in some regions, to control disease during high-risk periods. Effective disease management combines antibiotic treatment with vaccination, biosecurity, ventilation control and good husbandry, because antibiotics alone cannot compensate for poor environmental conditions.

Responsible Veterinary Use and Precautions

Tilmicosin is a prescription-only veterinary medicine. It must not be used in humans, and accidental self-injection of injectable formulations can be extremely dangerous. Personnel handling the product should follow the label warnings and seek immediate medical attention if accidental injection occurs. Treatment should follow veterinary diagnosis, respect withdrawal periods for slaughter, and avoid unnecessary use in order to reduce the risk of antimicrobial resistance.

Frequently Asked Questions

What class of antibiotic is tilmicosin? Tilmicosin is a semi-synthetic macrolide antibiotic derived from tylosin, used exclusively in veterinary medicine, and it carries the CAS number 108050-54-0.

Which swine diseases does tilmicosin treat? It is used for respiratory infections caused by Actinobacillus pleuropneumoniae, Pasteurella multocida and Mycoplasma species, the pathogens most frequently associated with the swine respiratory disease complex.

How does tilmicosin work? It binds reversibly to the 50S ribosomal subunit of susceptible bacteria and inhibits protein synthesis, producing a bacteriostatic to bactericidal effect depending on the concentration and the susceptibility of the organism.

Can tilmicosin be used in humans? No. It is a prescription-only veterinary medicine, and accidental self-injection of injectable formulations can be extremely dangerous and requires immediate medical attention.

Why is veterinary guidance required? To ensure correct diagnosis and dosing, compliance with withdrawal periods for slaughter, and responsible use that limits the development of antimicrobial resistance in pig production.

Is tilmicosin effective against Mycoplasma? Yes, tilmicosin has strong activity against Mycoplasma species, which often initiate or aggravate respiratory disease in growing pigs.

Send Inquiry